DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Sampson JH, Choi BD, Sanchez-Perez L. , et al.
EGFRvIII mCAR-modified T-cell therapy cures mice with established intracerebral glioma and generates host immunity against tumor-antigen loss.
Clin Cancer Res 2014;
20 (04) 972-984
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.